Sulfonylureas enhance GABAA synaptic potentials in rat midbrain dopamine neurones.
Grenhoff
J
J
Department of Pharmacology, Oregon Health Sciences University, Portland, USA.
Johnson
S W
SW
D000818:Animals; D004298:Dopamine / Q000502:physiology*; D004558:Electric Stimulation; D005913:Glipizide / Q000494:pharmacology; D005905:Glyburide / Q000494:pharmacology; D007004:Hypoglycemic Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D008636:Mesencephalon / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011963:Receptors, GABA-A / Q000187:drug effects*; D013453:Sulfonylurea Compounds / Q000494:pharmacology*; D013569:Synapses / Q000187:drug effects / Q000502:physiology*
D007004:Hypoglycemic Agents; D011963:Receptors, GABA-A; D013453:Sulfonylurea Compounds; D005905:Glyburide; D004298:Dopamine; D005913:Glipizide